0.00
price down icon100.00%   -3.41
after-market 시간 외 거래: 3.41 3.41 +
loading
전일 마감가:
$3.41
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$524.82M
수익:
$117.10K
순이익/손실:
$-161.61M
주가수익비율:
0.00
EPS:
-2.4059
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
Value
$0.00
$0.00
1주일 범위
Value
$0.00
$0.00
52주 변동 폭
Value
$0.00
$6.30

Opthea Limited Adr Stock (OPT) Company Profile

Name
명칭
Opthea Limited Adr
Name
전화
-
Name
주소
-
Name
직원
34
Name
트위터
Name
다음 수익 날짜
2024-09-04
Name
최신 SEC 제출 서류
Name
OPT's Discussions on Twitter

OPT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
OPT
Opthea Limited Adr
0.00 524.82M 117.10K -161.61M 0 -2.4059
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Opthea Limited Adr Stock (OPT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-25 다운그레이드 H.C. Wainwright Buy → Neutral
2025-03-25 다운그레이드 Jefferies Buy → Underperform
2025-03-25 다운그레이드 Leerink Partners Outperform → Market Perform
2025-03-24 다운그레이드 Oppenheimer Outperform → Perform
2022-12-08 개시 H.C. Wainwright Buy
2022-04-26 개시 SVB Leerink Outperform
2020-11-17 개시 Citigroup Buy
2020-11-11 개시 Oppenheimer Outperform
2020-11-11 개시 SVB Leerink Outperform
2020-11-11 개시 Truist Buy
모두보기

Opthea Limited Adr 주식(OPT)의 최신 뉴스

pulisher
Jul 26, 2025

Opthea (NASDAQ:OPT) Stock Price Up 7.2% – What’s Next? - Defense World

Jul 26, 2025
pulisher
Jul 19, 2025

Opthea Limited Depositary Receipt Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 04, 2025

Opthea (NASDAQ:OPT) Stock Price Up 7.2% – Time to Buy? - Defense World

Jul 04, 2025
pulisher
Jul 03, 2025

Opthea Limited Relocates Registered Office to Melbourne - TipRanks

Jul 03, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Reduces Stock Holdings in Opthea Limited (NASDAQ:OPT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Citadel Advisors LLC Takes $79,000 Position in Opthea Limited (NASDAQ:OPT) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Opthea Limited (NASDAQ:OPT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 09, 2025
pulisher
May 24, 2025

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail

May 24, 2025
pulisher
May 22, 2025

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), ACADIA Pharmaceuticals (ACAD) and Quanterix (QTRX) - The Globe and Mail

May 22, 2025
pulisher
May 20, 2025

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE) - The Globe and Mail

May 20, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Opthea Limited (NASDAQ:OPT) Given Average Rating of “Hold” by Analysts - Defense World

May 15, 2025
pulisher
May 08, 2025

Sarepta Therapeutics (SRPT) Gets a Buy from Oppenheimer - The Globe and Mail

May 08, 2025
pulisher
May 08, 2025

Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (SYRE), Fresenius Medical Care (FMS) and Jazz Pharmaceuticals (JAZZ) - The Globe and Mail

May 08, 2025
pulisher
Apr 23, 2025

Brokerages Set Opthea Limited (NASDAQ:OPT) PT at $1.33 - Defense World

Apr 23, 2025
pulisher
Apr 11, 2025

Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace

Apr 11, 2025
pulisher
Apr 10, 2025

Opthea Ltd shares corporate update in SEC filing - Investing.com

Apr 10, 2025
pulisher
Apr 08, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 08, 2025
pulisher
Apr 02, 2025

Opthea Announces Termination of ShORe and COAST Trials of Sozinibercept - HCPLive

Apr 02, 2025
pulisher
Mar 31, 2025

Opthea Halts Wet AMD Clinical Trials By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Opthea Halts Wet AMD Clinical Trials - Investing.com

Mar 31, 2025
pulisher
Mar 29, 2025

Opthea Limited (NASDAQ:OPT) Receives $1.33 Consensus PT from Brokerages - Defense World

Mar 29, 2025
pulisher
Mar 25, 2025

Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty - TipRanks

Mar 25, 2025
pulisher
Mar 24, 2025

Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Opthea COAST trial misses primary endpoint, enters talks with DFA Investors - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Opthea reports phase 3 trial results for eye treatment - Investing.com

Mar 24, 2025
pulisher
Mar 19, 2025

Promising Developments and Strong Financial Position Propel AbSci’s Growth Prospects - TipRanks

Mar 19, 2025
pulisher
Mar 10, 2025

Opthea Limited Announces New Securities Quotation on ASX - TipRanks

Mar 10, 2025
pulisher
Mar 05, 2025

Opthea Limited Reports Increased Losses Amid Clinical Advancements - TipRanks

Mar 05, 2025
pulisher
Feb 28, 2025

Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Opthea reports mid-year financial results - Investing.com

Feb 28, 2025
pulisher
Feb 26, 2025

Opthea Ltd completes key drug product campaign - Investing.com

Feb 26, 2025
pulisher
Feb 20, 2025

Opthea Completes Key Phase 3 Trial Milestone in Wet AMD Treatment - TipRanks

Feb 20, 2025
pulisher
Feb 19, 2025

Opthea Limited completes week 52 patient visits in the COAST trial - Ophthalmology Times

Feb 19, 2025
pulisher
Feb 18, 2025

Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position - TipRanks

Feb 18, 2025
pulisher
Feb 07, 2025

Opthea to Present at Oppenheimer Healthcare Conference - GlobeNewswire Inc.

Feb 07, 2025
pulisher
Feb 06, 2025

OPTOpthea Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Feb 06, 2025
pulisher
Jan 31, 2025

Is Opthea Limited (OPT) One of the Best ASX Stocks to Buy According to Hedge Funds? - Insider Monkey

Jan 31, 2025
pulisher
Jan 28, 2025

Opthea Unveils Promising Wet AMD Therapy at Investor Day - TipRanks

Jan 28, 2025
pulisher
Jan 27, 2025

Why Opthea (OPT) Is Among the Best Australian Stocks to Buy Now? - Yahoo Finance

Jan 27, 2025
pulisher
Jan 08, 2025

Opthea Sets Key 2025 Investor Events to Showcase Breakthrough Wet AMD Treatment Sozinibercept - StockTitan

Jan 08, 2025
pulisher
Dec 31, 2024

Opthea Limited Reports Earnings Results for the Half Year Ended December 31, 2024 - Marketscreener.com

Dec 31, 2024
pulisher
Dec 19, 2024

Opthea to Present Phase 3 Trial Update at J.P. Morgan Healthcare Conference - TipRanks

Dec 19, 2024
pulisher
Dec 18, 2024

Race Oncology bolsters leadership - The Australian

Dec 18, 2024
pulisher
Nov 19, 2024

Opthea Limited Targets AMD Market with Sozinibercept - TipRanks

Nov 19, 2024
pulisher
Nov 15, 2024

Opthea Appoints Kathy Connell to Board of Directors - The Manila Times

Nov 15, 2024
pulisher
Nov 12, 2024

Opthea's Wet AMD Program Featured at Ophthalmology Events - The Manila Times

Nov 12, 2024
pulisher
Nov 04, 2024

Opthea to Participate in November Investor Conferences - The Manila Times

Nov 04, 2024
pulisher
Oct 16, 2024

Is Opthea Limited (OPT) the Penny Stock with the Biggest Upside Potential According to Analysts? - Yahoo Finance

Oct 16, 2024

Opthea Limited Adr (OPT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
자본화:     |  볼륨(24시간):